Neoleukin Therapeutics, Inc. NLTX
3.49 +3.49
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -59.10M | -60.70M | -33.73M | -70.96M | -32.62M | |
| -57.56M | -60.69M | -33.28M | -69.44M | -31.59M | |
| -1.04 | -1.10 | -0.64 | -2.57 | -1.34 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 37.89M | 142.47M | 192.56M | 143.09M | 76.93M | |
| 115.95M | 163.26M | 210.52M | 147.02M | 77.62M | |
| 21.62M | 20.40M | 19.30M | 5.34M | 4.95M | |
| 12.07M | 12.98M | 12.12M | 1.21M | 15.00K | |
| 94.33M | 142.86M | 191.22M | 141.69M | 72.67M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -45.61M | -47.56M | -24.57M | -15.39M | -31.58M | |
| -59.13M | -3.26M | -2.22M | -688.00K | 55.95M | |
| 161.00K | 732.00K | 77.14M | 82.24M | 570.00K | |
| -1.11M | -3.26M | -2.22M | -879.00K | -49.00K | |
| -104.58M | -50.09M | 50.34M | 66.17M | 24.90M |